POSSIBLE ADVERSE INTERACTION BETWEEN CLOZAPINE AND AMPICILLIN IN AN ADOLESCENT WITH SCHIZOPHRENIA

被引:8
作者
CSIK, V
MOLNAR, J
机构
[1] Child and Adolescent Unit, Department of Neurology and Psychiatry
[2] Department of Microbiology, Albert Szent-Györgyi Medical University, Szeged
关键词
D O I
10.1089/cap.1994.4.123
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
A 17 year old with probable schizophrenia, who showed a therapeutic response to clozapine (12.5 mg t.i.d.), was treated for sinusitis with a routine dose of ampicillin (a semisynthetic penicillin). Within a day, the patient became sleepy, appeared distractible, performed routine activities slowly, and exhibited hypersalivation. There was no evidence of delirium, other neurotoxic or autonomic signs, or metabolic dysregulation. These changes disappeared promptly on replacement of ampicillin with a chemically unrelated antibiotic. Especially in view of the hypersalivation, a characteristic side effect of clozapine, it was hypothesized that there may be a drug interaction between clozapine and ampicillin. This hypothesis was further explored by use of differential absorption spectrophotometry to investigate the possibility of a molecular interaction between these two agents in vitro. Spectrophotometric findings suggest that clozapine interacts in vitro with ampillicin, as well as with penicillin G; a different type of drug interaction was observed with tetracycline, but there was no apparent interaction with streptomycin. Although the hypothesized drug interaction has not been fully demonstrated in a clinical setting, physicians may wish to be aware of the theoretical possibility of drug interactions between clozapine and certain antibiotics.
引用
收藏
页码:123 / 128
页数:6
相关论文
共 9 条
[1]  
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, (1987)
[2]  
Amminger G., Resch F., Reimitz J., Friedrich H., Nebenwirkungen von Clozapin in der Therapie psychotischer Zustandbilder bei Jugenlichen, Z Kinder-Jugendpsychiatr, 20, pp. 5-11, (1992)
[3]  
Birmayer B., Baker R., Kapur S., Quintana H., Ganguli R., Case study: Clozapine for the treatment of adolescents with schizophrenia, J Am Acad Child Adolesc Psychiatry, 31, pp. 160-164, (1992)
[4]  
Bunney B.S., Clozapine: A hypothesized mechanism for its unique clinical profile, Br J Psychiatry, 60, pp. 17-21, (1992)
[5]  
Eckert G.M., Gutmann F., Keyzer H., Electrochemical interactions between some beta-lactam antibiotics and aminoglycoside antibiotics, J Biol Phys, 13, pp. 43-49, (1985)
[6]  
Lieberman J.A., Kane J.M., Johns C.A., Clozapine: Guidelines for clinical management, J Clin Psychiatry, 50, pp. 320-338, (1989)
[7]  
Molnar J., Mandi Y., Regely K., Tarnoky K., Nakamura M.J., Inhibition of biological effects of endotoxins by phenothiazines, In Vivo, 6, pp. 205-210, (1992)
[8]  
Remschmidt J., Schulz E., Martin P.D.M., An open trial of clozapine in 36 adolescents with schizophrenia, J Child Adolesc Psychopharmacol, 4, pp. 31-41, (1994)
[9]  
Schmidt M.H., Trott G.E., Blanz B., Nissen G., Clozapine medication in adolescents, pp. 1100-1104, (1990)